The complement system is an essential component of the innate and acquired immune system 1 , and consists of a series of proteolytic cascades that are initiated by the presence of microorganisms. In health, activation of complement is precisely controlled through membrane-bound and soluble plasma-regulatory proteins including complement factor H (fH; ref. 2), a 155 kDa protein composed of 20 domains (termed complement control protein repeats). Many pathogens have evolved the ability to avoid immune-killing by recruiting host complement regulators 3 and several pathogens have adapted to avoid complement-mediated killing by sequestering fH to their surface 4 . Here we present the structure of a complement regulator in complex with its pathogen surface-protein ligand. This reveals how the important human pathogen Neisseria meningitidis subverts immune responses by mimicking the host, using protein instead of charged-carbohydrate chemistry to recruit the host complement regulator, fH. The structure also indicates the molecular basis of the host-specificity of the interaction between fH and the meningococcus, and informs attempts to develop novel therapeutics and vaccines.
The complement system is an essential component of the innate and acquired immune system 1 , and consists of a series of proteolytic cascades that are initiated by the presence of microorganisms. In health, activation of complement is precisely controlled through membrane-bound and soluble plasma-regulatory proteins including complement factor H (fH; ref.
2), a 155 kDa protein composed of 20 domains (termed complement control protein repeats). Many pathogens have evolved the ability to avoid immune-killing by recruiting host complement regulators 3 and several pathogens have adapted to avoid complement-mediated killing by sequestering fH to their surface 4 . Here we present the structure of a complement regulator in complex with its pathogen surface-protein ligand. This reveals how the important human pathogen Neisseria meningitidis subverts immune responses by mimicking the host, using protein instead of charged-carbohydrate chemistry to recruit the host complement regulator, fH. The structure also indicates the molecular basis of the host-specificity of the interaction between fH and the meningococcus, and informs attempts to develop novel therapeutics and vaccines.
Neisseria meningitidis is a human adapted pathogen of global importance as a leading cause of bacterial meningitis and septic shock 5 . Owing to Neisserial strain variation, the vaccines currently available for meningococcal disease are only effective against subsets of strains and do not provide universal protection 6, 7 . However, promising novel antigens have been identified 8 , including factor H binding protein (known as fHbp, GNA1870, or R2086), a 27 kDa surface lipoprotein which is present on the surface of all strains of N. meningitidis and elicits protective bactericidal antibodies 9, 10 . The structure of a portion of fHbp has been determined by NMR 11 , and its function studied by subdividing it into a series of regions, termed 'A', 'B' and 'C' 12 . fHbp is the sole receptor for fH on the meningococcus, and recruitment of fH contributes to the ability of the meningococcus to avoid innate immune responses by inhibiting complementmediated lysis in human plasma 13, 14 . Individuals with polymorphisms in the promoter of the gene encoding fH (also known as CFH) that are associated with increased plasma fH levels are at increased risk from meningococcal disease 15 .
We have used a range of approaches to dissect the fH binding sites on fHbp ( Fig. 1 ). High affinity interactions between fH and fHbp were only observed with fHbp constructs containing all three of the previously defined (see above) regions of fHbp ( Fig. 1a ), implying that fHbp has an extended recognition site for fH across its entire surface. We then sought to identify which of the 20 complement control protein (CCP) domains of fH mediate the interaction with fHbp. Far-western, FACS (fluorescence-activated cell sorting; Fig. 1b ) and SPR (surface plasmon resonance; Fig. 1c ) analyses demonstrated that the key regions of fH recognized by fHbp are the sixth and seventh domains, CCPs 6 and 7 (called hereafter fH67) and that a construct containing both these domains was capable of inhibiting the fHbp-dependent interaction between fH and N. meningitidis ( Fig. 1d ). Quantification of the interaction demonstrates that the dissociation constant is K d < 5 nM ( Fig. 1c and e; Supplementary  Table 1 , Supplementary Fig. 1 ) for any construct containing CCPs 6 and 7. This interaction was not dissociated by high salt (1 M NaCl, not shown) or pH ranging from 4 to 8 (not shown), providing additional support for the high affinity nature of the binding event.
To better understand fH/fHbp recognition, we crystallized and determined crystal structures of the complex between fH67 and a fHbp construct comprising regions A, B and C but lacking the lipid anchor. Models for fHbp and fH67 were built and refined to 2.35 Å in two crystal forms with a total of seven independent copies of the complex (Fig. 2) . The structure reveals that fHbp folds to form two b-barrels ( Fig. 2a ) with the amino-terminal barrel consisting of the A and part of the B regions, while the carboxy-terminal barrel (as previously seen in the NMR structure of the BC region 11 , overlaid in Supplementary Fig. 2 ) is composed of the rest of the B and the C regions. Searching structural databases with the N-terminal barrel reveals no close structural homologues (Supplementary Analyses), and the distinct topologies of the b-barrels ( Fig. 2c ) suggest that they have not arisen by a gene duplication event.
The fH67-fHbp complex is held together by extensive interactions between both b-barrels of fHbp and fH CCP6 ( Fig. 2b) , with more minor contacts to CCP7, consistent with our binding studies. In particular, the helical insertion into the second b-strand of CCP6 (an unusual feature of this CCP domain) is centrally located in the complex. Analysis by the PISA server (http://www.ebi.ac.uk/msd-srv/prot_int/ pistart.html) gives all seven independent complexes a significance score of 1.0 (that is, extremely likely to be biologically significant), with the average surface area of fHbp buried in the complex (2,860 6 177Å 2 ) greater than that buried in most antibody-antigen complexes 16 . Furthermore, the free energy change (DG) predicted on the basis of the structure for the formation of the complex (26 kcal mol 21 ) is in good agreement with the affinity derived from binding studies (211 kcal mol 21 , calculated from K d presented in Fig. 1e ), providing additional support for the physiological relevance of the crystallized complex. The interaction surface shows good shape complementarity with numerous electrostatic interactions ( Fig. 2c , Supplementary Fig. 3 ), including multiple hydrogen bonds and salt bridges.
To further probe the interaction surface, we generated doubly mutated forms of both proteins, with charged side chains being replaced by the small hydrophobic residue Ala (fH67 R341A,H337A and fHbp E283A,E304A ). Use of SPR to study the interactions between the mutated proteins and their wild-type partners revealed that the affinity of both mutant forms was reduced by more than two orders of magnitude, so that almost no interaction could be seen at analyte concentrations (,50 nM) around ten times the wild-type K d (Fig. 3a) . At 1,000-fold higher analyte concentration (mM range), the mutant forms of both proteins did interact with the wild-type partners: fHbp E283A,E304A retained a qualitatively similar on-rate but an increased off-rate with respect to wild-type, while fH67 R341A,H337A was more similar to the wild-type interaction in its off-rate but had a vastly reduced on-rate (Supplementary Table 1 ). It is interesting to note that E304 is not conserved in all Neisserial strains, with a Thr also found at this position 10 . Since these strains also sequester fH, it is likely that either the loss of a single interaction (rather than the two lost in the mutant) does not decrease the affinity sufficiently to preclude functional fH sequestration, or that subtle rearrangements of the local side chains allow the Thr side chain to interact with residues in fH. The ability of the interaction to tolerate some variation in the residues at the interface would clearly be immunologically advantageous.
A common fH polymorphism (fH 402 His/Tyr ), recently shown to be a major susceptibility factor for age related macular degeneration [17] [18] [19] , lies at the periphery of the interaction site, and the side chain of residue 402 (His in this structure) is within hydrogen-bonding distance of residues in fHbp ( Supplementary Figs 4 and 5 ). However, our interaction studies do not detect any differences in binding ( Fig. 1e , Supplementary Table 1 ) between the fH 402 His/Tyr isoforms. This lack of functional consequence suggests, as for variation at the 304 position (see above), two things: either (1) the loss of a single hydrogen bond from this extensive interaction surface is not sufficient to produce a functional effect; or (2) that the small amount of flexibility at the CCP 6/7 junction seen between the crystallographically independent copies of the complex allows subtle rearrangement of the fH CCP domains to enable both polymorphic variants to hydrogen bond to fHbp ( Supplementary Fig. 4 ).
Mapping published epitopes of fHbp that elicit bactericidal antibodies 11, 12 onto the structure demonstrates that none of the sites characterized to date lie directly in the fH recognition site. Instead, epitopes recognized by antibodies that affect fH binding 20 are located around the edge of the recognition site and so are likely to inhibit fH binding by steric hindrance ( Supplementary Fig. 5 ).
Our earlier structure 21 of CCPs 6, 7 and 8 of fH in complex with sucrose octasulphate (SOS), a highly sulphated analogue of glycosaminoglycans (GAGs), revealed a charged groove on fH that forms an extended interaction site for binding of GAGs on the surface of endothelial cells. This, combined with an additional GAG-binding site in CCPs 19-20 22 , provides the mechanism by which fH localizes to mammalian cells 23 to prevent inappropriate complement activation. Examination of the fHbp-fH67 complex demonstrates that the Neisserial protein binding site lies within this extended GAG interaction site, overlapping the CCP6 SOS-binding site ( Fig. 3b ) with no fH rearrangement upon binding fHbp ( Supplementary Fig. 6 ). There are several examples of pathogens imitating their host by expressing directly related molecules (for example, sialic acid or glycolipids 24 ). Here, however, N. meningitidis mimics the mechanism by which host cells regulate complement activation on their surface using amino acid side-chains instead of charged sugars. As the binding sites of fHbp and SOS on fH are overlapping, we tested whether SOS can act as a competitive inhibitor of the interaction between fH and fHbp. Strikingly, SOS prevented the fH/fHbp interaction (assessed by SPR in Fig. 3d , and by FACS in Supplementary Fig. 7 ) at millimolar concentrations, supporting the relevance of the crystal structure to complex formation in solution and providing a lead compound for development of small molecule inhibitors of fH/fHbp interactions. (note that where binding is seen the relative magnitude of the response is not significant since the amount of pAb bound is approximately proportional to the size of the fH construct rather than the tightness of the binding event). c, SPR demonstrates that fHbp is only able to bind fH constructs containing CCPs 6 and 7 (the number of molecules of the fH fragments coupled on the sensor channels is in the ratio 1 mutagenesis using Ala to substitute charged side-chains, shown by the structure to be involved in complex formation, abolishes binding to the wildtype form of their partner at concentrations around the wild-type K d . The black bar indicates the time period for which the fH analytes were injected (at 50 nM, 40 ml min 21 ) over the fHbp surfaces. b, Overlay of the fH-bound SOS (in gold as ball-and-stick and semi-transparent surface) from the structure of fH678 in complex with SOS 21 onto our fHbp-fH67 structure (coloured as in Fig. 2b ). This demonstrates that the sites of SOS and fHbp binding overlap, suggesting that SOS could inhibit the interaction. c, Mimicry of GAG binding to fH via sulphate interactions (left panel: SOS, green carbons; fH, grey carbons) by charged side chain (Glu 304) of fHbp (right panel: fHbp, cyan carbons; fH, grey carbons). d, SPR demonstrates that SOS inhibits binding of fHbp to fH in the mM concentration range (fH678 injected at 4 nM, 40 ml min 21 in presence of varying amounts of SOS). Values show mean 6 s.d., n 5 3. e, Mapping of sites of amino acid differences in CCP6 of fH between human (UniProt P08603) and rhesus macaque (UniProt O19279). Residues which are altered shown in pink, space filling representation, with fHbp and fH67 shown as in Fig. 2b . cartoon representation of fHbp (residues 80-320). The cartoon is coloured according to the regions previously used to study fHbp (A region, yellow; B region, green; C region, cyan), illustrating the way in which these constructs do not reflect the overall architecture. b, Cartoon of the fHbp-fH67 complex with fHbp coloured as in a and fH67 in dark blue. Side chains from both proteins involved in forming salt bridges across the interaction surface are shown in red as ball-and-stick representations (zoomed and reoriented in inset box). c, Topology of fHbp and fH67 coloured as in b with the number of the residues involved in either H-bond or salt-bridge interactions between the proteins highlighted in red. The numbering scheme used throughout is as per Uniprot sequence Q9JXV4. This scheme is offset by 1164 from the numbering used for the earlier NMR structure 11 (which was numbered from the start of their fragment) and by -65 from the scheme used in ref. 10 where numbering started from residue 1 of the mature protein without the signal sequence.
N. meningitidis has evolved to avoid innate responses at sites of colonization and during disease. It is also host-restricted, with the human nasopharynx its only natural reservoir 5 . This host specificity can limit the significance of animal models for studying certain aspects of pathogenesis and immunity. It has previously been shown that N. meningitidis only binds human fH and not fH from other primates or other animals 25 . The amino acid sequences of fH from human and other primates are highly conserved (,90% identity) while other animal fHs are more sequence divergent. It is therefore of note that even the limited number of differences in CCP6, between human and primate sequences, cluster to the precise site of interaction with fHbp. For instance, mapping the differences between human and rhesus macaque fH 26 shows that all six differences within CCP6 lie in or around the interface (Fig. 3e ). This indicates the likely structural basis for the species specificity of complement evasion 25 by N. meningitidis through fH recruitment, and suggests that specific modification of fH could provide a novel approach to the development of more biologically relevant models of meningococcal disease.
Interestingly, the high affinity interaction between fH and fHbp suggests that N. meningitidis could rapidly sequester fH in the plasma, depleting the circulating levels and de-regulating complement, rendering host cells in the vascular compartment more susceptible to complement-mediated damage. This might contribute to the dramatic haemorrhagic rash seen in meningococcal sepsis, and suggests that inhibitors specifically designed to block the interaction between CCP6 and fHbp might both promote complementmediated clearance of bacteria and prevent sequestration of fH and consequent vascular damage 27 .
The success of meningococcal vaccines containing fHbp that are currently being evaluated may be hampered by binding of fH which, due to the high affinity and the extensive sites of interaction, could cloak critical, conserved epitopes on the antigen. Structural analysis of this complex paves the way for the development of engineered fHbp vaccines in which fH binding is abolished to unveil the full array of protective epitopes, including those that could generate responses to inhibit recruitment of fH by this important human pathogen.
METHODS SUMMARY
Recombinant proteins were expressed and purified using affinity columns or size exclusion chromatography, and protein concentration estimated using absorbance at l 5 280 nm. Binding assays (FACS, far western and SPR) were performed according to published protocols. The complex was crystallized by vapour diffusion and X-ray diffraction data collected at the European Synchrotron Radiation Facility (ESRF, France) and DIAMOND (UK). The structure was solved by a combination of molecular replacement for the fH67 portion 21 (onethird of the structure) and isomorphous replacement/anomalous dispersion methods, with seven independent copies refined to 2.35 Å in two different crystal forms.
METHODS
Western blot analysis. Protein samples were separated by SDS-PAGE, then transferred to PVDF membranes at 15 V for 60 min. The membranes were blocked in 5% milk in PBS at 4 uC overnight, rinsed once in PBSTM (PBS, 0.05% Tween20, 0.5% skimmed milk), then incubated with primary antibodies or a source of fH for 1-2 h at room temperature. After three washes in PBSTM, membranes were incubated with goat anti-human fH pAbs (at a 1:1,000 final dilution) or murine anti-fHbp pAbs (at a 1:10,000 final dilution) in PBS. Binding was detected with an anti-rabbit peroxidase conjugated IgG (Dakocytomation) used at 1:500 dilution. Flow cytometry analysis. A total of 10 8 N. meningitidis were incubated with 10 ml of purified fH (2 mM) or CCPs (final concentration, 3 mM) for 30 min at 37 uC. After three washes with PBS-0.1% Tween20 (PBST), bacteria were incubated for 30 min with a mAb MRC OX24 28, 29 or with anti-human fH pAbs in PBS. After three washes in PBST, cells were incubated with a secondary, FITC-conjugated antibody for 30 min in the dark at 4 uC. fH bound to meningococci was detected by flow cytometry using a FACS Calibur analyser (Becton Dickinson). For inhibition assays, full length fH was incubated with bacteria together with increasing concentrations of CCPs 6 and 7 as indicated with binding of full length fH detected using the anti-CCP5 mAb MRC OX24 28, 29 , or with SOS (Toronto Research Chemicals). Results are expressed as the mean fluorescence index (geometric mean fluorescence multiplied by the percentage positive cells). Expression of proteins and purification of the complex. fHbp and truncated versions of the protein were expressed in E. coli BL21(DE3) host cells as polyhistidine-tagged fusion proteins at their C terminus 14 Cultures of the strains were grown to mid-log phase and expression induced with isopropyl-D-thiogalactoside (IPTG, 1 mM final concentration). Proteins were purified by affinity chromatography on a His-Trap column according to the manufacturer's instructions (GE Healthcare), and eluted from columns with 250 mM imidazole. fH constructs were expressed in E. coli as previously described 30 (with refolding to allow correct formation of the four disulphide bonds within the two CCP fragments) and purified either by heparin column affinity purification or by size exclusion chromatography. Following mixing of fHbp with fH67 (at a large molar excess), the complex was purified by size exclusion chromatography (Superdex S-200, GE Healthcare, buffer 50 mM Tris pH 7.5, 150 mM NaCl) where the strong interaction seen between the uncomplexed fH67 and the column matrix ensured good separation of the peak containing the complex and that containing the excess fH67. Presence of both proteins in the putative complex peak was confirmed by SDS-PAGE and mass spectrometry (data not shown). Site-directed mutagensis. Double mutants were generated in a sequential fashion using the QuikChange site-directed mutagenesis kit (Stratagene). The R341A, H337A double mutant form of fH67 was generated using the following primers: H337A forward, 59-AAACATGGAGGTCTATATGCTGAGAATATG CGTAGACCATACTTTCC-39; H337A reverse, 59-TTTGTACCTCCAGATAC GACTCTTATACGCATCTGGTATGAAAGG-39. R341A forward, 59-GGTCTA TATCATGAGAATATGGCTAGACCATACTTTCCAGTAGC-39; R341A reverse, 59-CCAGATATAGTACTCTTATACCGATCTGGTATGAAAGGTCATCG-39. Introduction of the mutation was confirmed by sequencing. Recombinant mutant fH67 fragments were expressed and refolded from inclusion bodies as previously described 30 . For generation of the E283A, E304A fHbp the primers used were: E283A forward 59-ACAACCAAGCCGCGAAAGGCAGTTAC-39; E283A reverse, 59-GTAACTGCCTTTCGCGGCTTGGTTGT-39; E304A forward 59-TGCCGG CAGCGCGGCAGTGAAAACCG-39; E304A reverse 59-CGGTTTTCACTGCCG CGCTGCCGGCA-39 and the protein expressed and purified as described above. Surface plasmon resonance. Either fHbp or fH constructs were coupled to the sensor surface (CM5 chips) using standard amine coupling protocols. The appropriate ligand was then flowed in the fluid phase (buffer HEPES buffered saline) at a flow rate of 40 ml min 21 . A control trace was collected using either a mock-coupled channel or an unrelated protein-coupled channel. Fits were performed to control-subtracted traces such as those shown in Fig. 1 . The strong interaction was not disrupted using either high/low salt (0 to 3 M NaCl) or extreme pH (range 4 to 8 tried) and extended dissociation time (60 min) was therefore used between successive injections. The data obtained with the larger fHbp in the fluid phase could not be satisfactorily fitted using a simple 1:1 model (presumably due either to issues of movement of the larger protein into/out of the chip matrix or steric hindrance in the fH binding site introduced by coupling of the smaller protein to the chip surface), crude analysis of near-equilibrium values suggested a K d in the tens to hundreds of nM range (depending on the fH construct used). Once the interaction was reversed (with fH on the chip) the data could be satisfactorily fitted ( Supplementary Table 1; Fig. 1c , inset and Supplementary Fig. 1 ) using a 1:1 Langmuir model with satisfactory x 2 revealing that the true K d for the constructs containing CCP6 was of the order of 5 nM irrespective of the flow rate, injection time and density of fHbp coupled to the chip surface (see main text, Supplementary Table 1 ). The fH67 and fHbp double mutants were also analysed with the fHbp partner coupled to the chip surface (fHbp WT ,800 RU coupled on channel 1, fHbp E283A,E304A ,1,500 Response Units (RU) coupled on channel 2). fH67 (wild type and mutant) were then flowed over at a concentration of 50 mM (,103 the native K d ) revealing little or no interaction from the mutants with their wild type partner compared to the magnitude of interaction seen with both proteins in the wild type form. To calculate the affinity of fH67 R341A,H337A for fHbp WT , a series of injections (in duplicate) spanning the concentration range 250 nM to 20 mM was used and fitted using the BiaEvaluation software to give the values shown in Supplementary Table 1 . Inhibition assays were calculated by injecting a constant concentration of fH67 or fH678 over a fHbp-coupled surface with/without inhibitor (SOS in Fig. 3d or heparin in Supplementary Fig. 8 ) present. The binding signal obtained is then reported as a percentage of the binding seen in the absence of inhibitor. Values are given as a mean with standard deviations as shown from three independent pairs of injections. SPR studies using full length fH purified from plasma also showed an interaction ( Supplementary Fig. 9 ) with fHbp on the sensor chip surface and fH in the fluid phase. These data could not be satisfactorily fitted, presumably due to complex kinetics caused by the difficulties of diffusing a large, flexible, molecule into the dextran matrix. However, concentrations of fH in the 10 nM range could be seen to interact, suggesting that the affinity for the full length fH is in the same range as that for the smaller fragments. Attempts to couple full length fH to the chip surface resulted in a coupling which prevented binding of fHbp (data not shown) and so could not be used to quantify the interaction. Crystallization and X-ray data collection. The crystals were grown using the sitting drop vapour diffusion method from 0.2 ml complex 1 0.2 ml mother liquor drops (complex at 4.5 mg ml 21 calculated using an assumed extinction coefficient of 2.2, mother liquor optimized around JCSG-plus condition 15, 20% polyethylene glycol (molecular weight 6,000), 0.1 M Bicine pH 9.0). Harvesting of crystals and SDS-PAGE confirmed that both fH67 and fHbp were present (data not shown). Crystals (usually 50 3 10 3 5 mm) were flash frozen in liquid nitrogen following cryoprotection with 15% ethylene glycol. Data were collected at both the ESRF and DIAMOND by the rotation method using either an oscillation range of 0.5u or 1u with the crystal kept at 120 K. The native P1 data were collected at beamline ID14eh4 (ESRF) with l 5 0.9523 Å , the native C2 and Pt sets were collected at beamline I03 (DIAMOND) with l 5 0.9814 Å , the Hg set at beamline BM14 (ESRF) with l 5 1.003 Å and the S-SAD at beamline ID29 (ESRF) with l 5 1.8 Å . Data were integrated and scaled using xia2 (http:// www.ccp4.ac.uk/xia/) 31 with the -3d option to force use of program XDS 32 for integration and program Scala 33 for inter-frame scaling. Structure solution and refinement. The structure of the fH67-fHbp complex was solved in the C2 crystal form by a combination of molecular replacement with the structure of fH67 (taken from the earlier structure of fH678 in complex with sucrose octasulphate, SOS, PDB ID 2UWN 21 ) and MIRAS methods using Pt, Hg derivatives and the anomalous scattering from 31 of the 33 sulphurs present in the C2 asymmetric unit. Three copies of fH67 were found using MolRep 35 (CCP4 Program Suite 36 ) and the two CCP domains rigid body refined using Buster-TNT 37 without modelling of missing atoms. These phases were then incorporated into a SHARP 38 phasing job and used to locate the heavy atom sites in the other crystals (6 Pt, 1 Hg and 31 S). The heavy atom model was refined in SHARP 38 (with B factor fixed to the Wilson value for each crystal) using data to 3.2 Å and the phases generated combined with those from the molecular replacement within SHARP to generate phases with a figure of merit of 0.54 (0.35 for the highest resolution shell 3.3-3.2 Å ). The phasing powers for the derivatives were (anomalous/isomorphous) 0.7/2.4 for the Pt, 0.2/0.3 for the Hg and 0.3/0.0 for the anomalous sulphur signal. The map obtained using these phases was solvent flattened within SHARP 38 and averaged in DM 39 using three separate operators for the fHbp, fH CCP6 and fH CCP7 regions. The NMR model 11 for the C-terminal barrel of fHbp could not be placed in this density (the strands were seen to be distorted) so a model was built by hand using program Coot 40 . Rebuilding and refinement using data in the range 40-2.35 Å proceeded using Coot 40 and Buster-TNT 37 with non crystallographic symmetry used to restrain the core of each domain while more variation was allowed between the loop region until the R/R free were 25.5/27.1 with no residues in the disallowed regions of the Ramachandran plot (94.6% in the most favoured, as determined by MolProbity 41 ). The model contains all residues of fH67 and all but five residues at the N terminus of fHbp and the six histidines of the affinity tag which are disordered in all copies of the molecule. Molecular replacement of the individual domains (fH CCP6 and CCP7 and fHbp) using program MolRep 35 allowed solution of the P1 crystal form (four independent copies of the complex in a different packing arrangement). Minor rebuilding of the loop regions and refinement (90-2.35 Å ) using Coot 40 /Buster-TNT 37 led to R/R free of 23.2/26.3 once again with no residues in the disallowed regions of the Ramachandran plot
